Pitofsky Jason
SEC insider (Form 3/4/5 filer). CIK 0002009236. SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN). 20 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in TARRYTOWN, NY.
Companies Pitofsky Jason has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Officer, SVP Controller
Pitofsky Jason
CIK: 0002009236
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect1 shares at avg. $784.66$784.66 - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect144 shares at avg. $783.23$113K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect53 shares at avg. $785.72$42K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect1K shares at avg. $492.00$492K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect20 shares at avg. $775.95$16K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect521 shares at avg. $776.43$405K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect391 shares at avg. $777.51$304K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect563 shares at avg. $778.35$438K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect205 shares at avg. $779.56$160K - Feb 9, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect75 shares at avg. $780.06$59K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 1 | $784.66 | $785 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 144 | $783.23 | $112,785 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 53 | $785.72 | $41,643 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 1,000 | $492.00 | $492,000 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 20 | $775.95 | $15,519 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 521 | $776.43 | $404,520 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 391 | $777.51 | $304,006 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 563 | $778.35 | $438,211 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 205 | $779.56 | $159,810 | Direct |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 75 | $780.06 | $58,504 | Direct |
1-10 of 20 transactions